Green View Magazine | December 2019

28 GREEN VIEW MAGAZINE DECEMBER 2019 in the United States, it is exceptionally difficult for companies to get medical grade cannabis to conduct research into potential medical applications. For this reason, many companies, such as Cannabics, have turned to Israel to conduct their research. Cannabis research has a relatively long history in Israel, dating back to the 1960s, when Raphael Mechoulam, an organic chemist and professor, was able to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC) in marijuana. “From this initial study, Israel has expanded its research to find potential areas of application for cannabis. While other European countries are making strides into the research of cannabis, Israel is considered by many experts to be the furthest ahead. This research includes exploring the potential of cannabis in the following areas: Cancer; Pain; Inflammation and stress management; Immunity; Metabolism; Drug delivery and nanotechnology; Pharmaceutical chemistry; Neuroscience; Plant science and genetics.” CANNAB I CS PHARMACEUT I CALS INC . INVESTMENT